Ribavirin antagonizes the effect of azidothymidine on HIV replication
- PMID: 2435003
- DOI: 10.1126/science.2435003
Ribavirin antagonizes the effect of azidothymidine on HIV replication
Abstract
Azidothymidine and ribavirin both inhibit replication of human immunodeficiency virus in vitro and show promise of clinical utility in patients infected with this virus. In this study, the possible interactions of these drugs were examined in vitro, and a reproducible antagonism between azidothymidine and ribavirin was found to occur under a variety of experimental conditions. The mechanism responsible for this antagonism appeared to be inhibition of azidothymidine phosphorylation by ribavirin. Because similar effects may occur in vivo, clinical trials of these two drugs in combination must be performed only under carefully controlled conditions.
Similar articles
-
Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.Proc Natl Acad Sci U S A. 1986 Nov;83(21):8333-7. doi: 10.1073/pnas.83.21.8333. Proc Natl Acad Sci U S A. 1986. PMID: 2430286 Free PMC article.
-
Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro.Antimicrob Agents Chemother. 1987 Oct;31(10):1613-7. doi: 10.1128/AAC.31.10.1613. Antimicrob Agents Chemother. 1987. PMID: 3435108 Free PMC article.
-
Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon.Antimicrob Agents Chemother. 1987 Feb;31(2):168-72. doi: 10.1128/AAC.31.2.168. Antimicrob Agents Chemother. 1987. PMID: 3471180 Free PMC article.
-
Spectrum of antiviral activity and mechanism of action of zidovudine. An overview.Am J Med. 1988 Aug 29;85(2A):176-81. Am J Med. 1988. PMID: 3044082 Review.
-
Zidovudine.Mo Med. 1989 Nov;86(11):741-3. Mo Med. 1989. PMID: 2682195 Review.
Cited by
-
Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.Drugs. 1989 Apr;37(4):408-50. doi: 10.2165/00003495-198937040-00003. Drugs. 1989. PMID: 2661194 Review.
-
Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine.Antimicrob Agents Chemother. 1991 Oct;35(10):2003-11. doi: 10.1128/AAC.35.10.2003. Antimicrob Agents Chemother. 1991. PMID: 1722077 Free PMC article.
-
Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action.Clin Pharmacokinet. 2010;49(1):17-45. doi: 10.2165/11318110-000000000-00000. Clin Pharmacokinet. 2010. PMID: 20000887 Review.
-
Therapeutic issues in HIV/HCV-coinfected patients.J Viral Hepat. 2007 Jun;14(6):371-86. doi: 10.1111/j.1365-2893.2006.00816.x. J Viral Hepat. 2007. PMID: 17501757 Free PMC article. Review.
-
Functionalized Nanoparticles in Prevention and Targeted Therapy of Viral Diseases With Neurotropism Properties, Special Insight on COVID-19.Front Microbiol. 2021 Nov 15;12:767104. doi: 10.3389/fmicb.2021.767104. eCollection 2021. Front Microbiol. 2021. PMID: 34867899 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources